Subtype
Brain Neoplasm
CI-CAN-00002030Explore in graph →
Non-malignant512 active trials34 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00002030Explore in graph →
Clinical trials
2,118 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02389530 | Use of Fluorescein Dye for the Removal of Brain Tumors | completed | — | 91 | University of PittsburghOTHER | 1 | Aug 3, 2018 | clinicaltrials |
| NCT00679354 | Cilengitide in Treating Younger Patients With Recurrent or Progressive High-Grade Glioma That Has Not Responded to Standard Therapy | completed | Phase 2 | 30 | National Cancer Institute (NCI)NIH | 2 | Aug 1, 2018 | clinicaltrials |
| NCT01151670 | Pioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Treating Patients With Brain Tumors | completed | Phase 1 | 18 | Wake Forest University Health SciencesOTHER | 1 | Aug 1, 2018 | clinicaltrials |
| NCT03248544 | Therapeutic Benefit of Preoperative Supplemental Vitamin D in Patients Undergoing Brain Tumor Surgery | completed | N/A | 60 | Shahid Beheshti UniversityOTHER | 1 | Jul 31, 2018 | clinicaltrials |
| NCT00749723 | Therapy Optimization Trial for the Treatment of Relapsed or Refractory Brain Tumors in Children(HIT-REZ-2005) | completed | Phase 2 / Phase 3 | 174 | University Hospital, BonnOTHER | 1 | Jul 20, 2018 | clinicaltrials |
| NCT02843477 | Evaluation of Corrected Carotid Artery Flow Time as a Predictor of Fluid Responsiveness in Spontaneous Breathing Patients | completed | — | 54 | Yonsei UniversityOTHER | 1 | Jul 17, 2018 | clinicaltrials |
| NCT00805376 | DNX-2401 (Formerly Known as Delta-24-RGD-4C) for Recurrent Malignant Gliomas | completed | Phase 1 | 37 | DNAtrix, Inc.INDUSTRY | 1 | Jul 16, 2018 | clinicaltrials |
| NCT00919750 | Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors | completed | — | 1,258 | Children's Oncology GroupNETWORK | 6 | Jul 16, 2018 | clinicaltrials |
| NCT00107003 | GW572016 to Treat Recurrent Malignant Brain Tumors | completed | Phase 2 | 9 | National Cancer Institute (NCI)NIH | 1 | Jul 5, 2018 | clinicaltrials |
| NCT01259479 | Satraplatin in Children and Young Adults With Refractory Solid Tumors Including Brain Tumors | completed | Phase 1 | 9 | National Cancer Institute (NCI)NIH | 1 | Jul 5, 2018 | clinicaltrials |
| NCT00335764 | Sorafenib Combined With Erlotinib, Tipifarnib, or Temsirolimus in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma | completed | Phase 1 / Phase 2 | 92 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2018 | clinicaltrials |
| NCT01644955 | Carboplatin in Treating Patients With Recurrent High-Grade Gliomas | completed | Phase 1 | 10 | James ElderOTHER | 1 | Jul 2, 2018 | clinicaltrials |
| NCT03574467 | Functional Outcomes of The Bobath Approach on Patients With Brain Tumors: Comparison With Stroke Patients | completed | — | 32 | Hacettepe UniversityOTHER | 1 | Jul 2, 2018 | clinicaltrials |
| NCT01459237 | Effects of Hormone Stimulation on Brain Scans for Cushing s Disease | completed | Early Phase 1 | 30 | National Institute of Neurological Disorders and Stroke (NINDS)NIH | 1 | Jun 14, 2018 | clinicaltrials |
| NCT01988675 | MRI Study of Radiation-Induced Damage to White Matter and Blood-Brain-Barrier | completed | — | 91 | University of Michigan Rogel Cancer CenterOTHER | 1 | Jun 6, 2018 | clinicaltrials |
| NCT01648348 | Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme | completed | Phase 1 / Phase 2 | 116 | National Cancer Institute (NCI)NIH | 1 | May 23, 2018 | clinicaltrials |
| NCT00077207 | Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade Glioma | completed | N/A | 66 | Children's Oncology GroupNETWORK | 1 | May 16, 2018 | clinicaltrials |
| NCT01252797 | Dose Escalation/De-escalation Study of Pre-operative Stereotactic Radiosurgery for Brain Metastases(RAD 1002)(RAD 1002) | completed | Phase 1 | 20 | University of Alabama at BirminghamOTHER | 1 | May 14, 2018 | clinicaltrials |
| NCT01124461 | BIRN (Biomedical Informatics Research Network) Resources Facilitate the Personalization of Malignant Brain Tumor(CONDR) | completed | — | 112 | Washington University School of MedicineOTHER | 1 | May 11, 2018 | clinicaltrials |
| NCT00890786 | A Study of Bevacizumab Therapy in Patients With Newly Diagnosed High-Grade Gliomas and Diffuse Intrinsic Pontine Gliomas | completed | Early Phase 1 | 27 | Children's Hospital Medical Center, CincinnatiOTHER | 1 | May 2, 2018 | clinicaltrials |
| NCT00832598 | [18F] FACBC and [18F] FLT PET Imaging in Central Nervous System Tumors | completed | N/A | 13 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 27, 2018 | clinicaltrials |
| NCT01234740 | Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases | completed | Phase 1 | 7 | City of Hope Medical CenterOTHER | 1 | Apr 17, 2018 | clinicaltrials |
| NCT02084134 | Peri-Operative Steroid Management in Patients(Steroid) | completed | N/A | 43 | Washington University School of MedicineOTHER | 1 | Apr 11, 2018 | clinicaltrials |
| NCT02884947 | Improving Surgical Outcomes in Patients With Low Grade Gliomas Using Advanced Pre- and Intra-operative MRI | completed | — | 31 | University College, LondonOTHER | 1 | Apr 9, 2018 | clinicaltrials |
| NCT00339300 | A Case-Referent Study of Brain Tumors in Adults | completed | — | 1,581 | National Cancer Institute (NCI)NIH | 1 | Apr 5, 2018 | clinicaltrials |
| NCT01512147 | Dexmedetomidine on Intraoperative Somatosensory and Motor Evoked Potential Monitoring During Neurosurgery in Pediatric Patients | completed | N/A | 20 | Oregon Health and Science UniversityOTHER | 1 | Apr 5, 2018 | clinicaltrials |
| NCT00003456 | Antineoplaston Therapy in Treating Patients With Newly-diagnosed Glioblastoma Multiforme | completed | Phase 2 | 40 | Burzynski Research InstituteOTHER | 1 | Mar 22, 2018 | clinicaltrials |
| NCT00003474 | Antineoplaston Therapy in Treating Adults With Residual/Recurrent/Progressive Glioblastoma Multiforme | completed | Phase 2 | 40 | Burzynski Research InstituteOTHER | 1 | Mar 22, 2018 | clinicaltrials |
| NCT01866228 | Clinical Trial of the Impact of Treatment Consultation Recordings on Cancer Patient Outcomes | completed | N/A | 140 | University of ManitobaOTHER | 1 | Feb 20, 2018 | clinicaltrials |
| NCT00047320 | Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors | completed | Phase 2 | 104 | Children's Oncology GroupNETWORK | 5 | Feb 14, 2018 | clinicaltrials |
| NCT00782756 | Bevacizumab, Temozolomide and Hypofractionated Radiotherapy for Patients With Newly Diagnosed Malignant Glioma | completed | Phase 2 | 40 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 6, 2018 | clinicaltrials |
| NCT02261649 | Impact of Cerebellar Mass Resection on Pain Processing | completed | — | 24 | Dana-Farber Cancer InstituteOTHER | 1 | Feb 1, 2018 | clinicaltrials |
| NCT01342757 | Magnetic Resonance Spectroscopy Imaging in Predicting Response to Vorinostat and Temozolomide in Patients With Recurrent or Progressive Glioblastoma | completed | N/A | 12 | National Cancer Institute (NCI)NIH | 1 | Jan 29, 2018 | clinicaltrials |
| NCT02791360 | Evaluation of Anatomy, Clinical and Neuropsychological Long-term Sequelae of Patients Treated With Radiation Therapy for Brain Tumor(TCSEQ) | completed | N/A | 15 | Centre Francois BaclesseOTHER | 1 | Jan 26, 2018 | clinicaltrials |
| NCT02574793 | Glycemic Fluctuations in Newly Diagnosed Growth Hormone-Secreting Pituitary Adenoma and Cushing Syndrome Subjects | completed | — | 60 | Huashan HospitalOTHER | 1 | Jan 23, 2018 | clinicaltrials |
| NCT01737671 | Methotrexate Infusion Into the Fourth Ventricle in Children With Malignant Fourth Ventricular Brain Tumors: A Pilot Study | completed | Early Phase 1 | 7 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 19, 2018 | clinicaltrials |
| NCT01601314 | Perioperative Magnesium Sulphate as a Cerebral Protector in Neurosurgical Patients(MAGNA) | completed | Phase 3 | 55 | Sara VareaOTHER | 1 | Jan 17, 2018 | clinicaltrials |
| NCT01480479 | Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma(ACT IV) | completed | Phase 3 | 745 | Celldex TherapeuticsINDUSTRY | 24 | Jan 16, 2018 | clinicaltrials |
| NCT00387790 | Motexafin Gadolinium and Radiation Therapy in Treating Young Patients With Pontine Glioma | completed | Phase 2 | 64 | National Cancer Institute (NCI)NIH | 1 | Jan 4, 2018 | clinicaltrials |
| NCT00760409 | Differentiating Recurrent Brain Tumor Versus Radiation Injury Using MRI | completed | — | 28 | University of MichiganOTHER | 1 | Dec 22, 2017 | clinicaltrials |
| NCT01753713 | Dovitinib in Treating Patients With Recurrent or Progressive Glioblastoma | completed | Phase 2 | 33 | Manmeet Ahluwalia, MDOTHER | 1 | Dec 12, 2017 | clinicaltrials |
| NCT02457715 | Feasibility of a Consumer Based Accelerometer in Monitoring Outpatient Physical Activity: A Study in Patients With Cancer and Amyotrophic Lateral Sclerosis | completed | — | 40 | Duke UniversityOTHER | 1 | Dec 12, 2017 | clinicaltrials |
| NCT03363126 | Visual Outcome After Transsphenoidal Surgery for Pituitary Macroadenoma(RetroADEN) | completed | — | 88 | Fondation Ophtalmologique Adolphe de RothschildNETWORK | 0 | Dec 6, 2017 | clinicaltrials |
| NCT01171469 | Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor | completed | Phase 1 | 8 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Dec 2, 2017 | clinicaltrials |
| NCT00381797 | Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma | completed | Phase 2 | 97 | National Cancer Institute (NCI)NIH | 1 | Nov 28, 2017 | clinicaltrials |
| NCT00649207 | A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain Metastases | completed | Phase 1 | 80 | AbbVie (prior sponsor, Abbott)INDUSTRY | 3 | Nov 21, 2017 | clinicaltrials |
| NCT02707549 | Fluid Therapy During Brain Tumor Resection in Children | completed | Phase 2 | 53 | Federal University of São PauloOTHER | 1 | Nov 14, 2017 | clinicaltrials |
| NCT01172964 | A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas | completed | Phase 1 | 15 | City of Hope Medical CenterOTHER | 1 | Nov 9, 2017 | clinicaltrials |
| NCT03338075 | FSRT Combined With TMZ for Large BMs: a PSM Study | completed | — | 72 | Chinese Academy of Medical SciencesOTHER | 0 | Nov 9, 2017 | clinicaltrials |
Data updated 23 days agoSource updated Aug 3, 2018source: clinicaltrials